Trial: 202007036

A phase II study of maintenance vorolanib and atezolizumab in patients with extensive-stage SCLC

Phase

II

Principal Investigator

Morgensztern, Daniel

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov